Provider Networks
Expert articles and analysis related to provider networks.
AI Summary — Last 7 Days
CMS’s proposed 2027 Medicare Physician Fee Schedule is intensifying momentum toward accountable care: the agency is proposing physician-payment reforms that would phase out MIPS, strengthen primary care payment, and expand ACO participation, while provider groups including ACP, NAACOS, and HCTTF are backing bipartisan Patients First Act efforts to modernize Medicare physician payment and support accountable care infrastructure (Fierce Healthcare). At the same time, network strategy is becoming more central to VBC economics
Related Articles
Draft guidance released for 2028 cycle of Medicare drug price negotiations
Draft guidance released for 2028 cycle of Medicare drug price negotiations American Hospital Association
Midsize biotechs press White House to drop CMS pricing rules
A number of midsize biotech companies have met with White House and HHS officials in the last week, presenting their case for why two pending CMS pricing models could hinder their business and should ...
The price of Ozempic is a meaningless phrase
By JOHN SAMARAS Ask what Ozempic costs. The honest answer runs from $25 a month to $1,100 a month, and every number in that range is real, published, and defensible. A phraseContinue reading...
15 More Medicare Drugs Are Getting Price Cuts in 2027
15 More Medicare Drugs Are Getting Price Cuts in 2027 - Find Out If Yours Is on the List AOL.com
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.
CVS Caremark reaches settlement with FTC over insulin suit
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost versions of drugs on st...
TrumpRx at 6 months: Has the drug-pricing experiment delivered?
TrumpRx at 6 months: Has the drug-pricing experiment delivered? Becker's Hospital Review
Drug costs are becoming hospitals’ fastest-growing financial threat
Drug costs are becoming hospitals’ fastest-growing financial threat Becker's Hospital Review
FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs
AHA challenges HRSA’s burden estimate for proposed 340B rebate model
AHA challenges HRSA’s burden estimate for proposed 340B rebate model American Hospital Association